Directly treats the inflammation of thyroid orbitopathy |
Can be utilised in the active phase of disease when surgery is not a good option |
Minimises congestion, ache, injection and periorbital oedema |
Decreases proptosis and dysmotility caused by acute inflammation |
Alleviates visual dysfunction caused by acute optic nerve compression |
The risks of general anaesthesia are eliminated |
No bruising, swelling, or discomfort |
Hospitalisation not required |
Safe with minimal side effects in non-diabetic adults |